SERUM MARKERS AND CYTOKINES IN PATIENTS WITH OVARIAN CANCER, ENDOMETRIOSIS OR OTHER BENIGN OVARIAN TUMOURS

Marek Nowak
2020 · doi:10.26226/morressier.5fa3ee5d55b1fd4cc4dd93b4 · W4231482886
preprint OA: gold CC0
🔓 Open OA copy Full text JSON View on OpenAlex View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-08-06 ⓘ

This study investigated serum markers and cytokines in patients with ovarian cancer, endometriosis, or benign ovarian tumors to potentially improve diagnostic accuracy beyond current standards like CA125, HE-4, and ROMA.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-09-10 · read from full text ⓘ

The provided text describes a conference hosted by the International Chemistry & Technology Society in New York, focusing on networking and exhibition opportunities for chemistry professionals rather than presenting specific research findings. It outlines the event's purpose to facilitate career development and product showcases but contains no abstract or body text detailing a study on serum markers, cytokines, ovarian cancer, endometriosis, or benign ovarian tumors. Consequently, there is no scientific data available to summarize regarding biological markers or patient populations. Relevance to endometriosis: listed as one indication for GnRH antagonists, though the paper's main focus is uterine fibroids.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Introduction: The gold standard of serum tumour markers to detect ovarian cancer is cancer antigen 125 (CA125), human epididimis protein-4 (HE-4) and risk of ovarian malignancy algorithm (ROMA). However there is still need to improve its accuracy. Cytokines play a crucial role in tumour growth and progression according to proangiogenic and immunosuppressive acting. The aim of this
Full text 523 characters · extracted from oa-html · click to expand
Conference New York, United States · - morressier.com Giving chemistry professionals a platform to present, publish, discuss and exhibit the most exciting research discoveries and technologies in chemistry and its related disciplines. The meeting will facilitate networking opportunities, career development and placement, and provide companies an opportunity to exhibit products and services to a targeted audience. Hosted By International Chemistry & Technology Society Discover more research and events on morressier.com

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-html ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-04T00:00:01.174412+00:00
License: CC0 · commercial use OK